The Penn Frontotemporal Degeneration Center brings together an energetic team of creative clinicians and researchers dedicated to the investigation and treatment of early onset neurodegenerative conditions.
Frontotemporal degeneration (FTD) refers to a family of disorders characterized by the progressive loss of neurons (brain cells) in the frontal and temporal regions of the brain.
The Penn Frontotemporal Degeneration Center learns a great deal about Frontotemporal degeneration by studying patients who have been diagnosed with a Frontotemporal degeneration spectrum disorder.
The Penn FTD Center offers a unique diversity of clinical and research expertise that spans many levels of neuroscience ranging from detailed clinico-pathological studies, biomarker discovery, genetics, neuropsychological studies, functional and structural neuroimaging, and cognitive neuroscience investigations of language, memory, and social cognition.
Dr. David Irwin of the Penn FTD Center discusses how improving the ability to distinguish between FTD subtypes is crucial to both clinical treatment and research
Penn FTD Center In the News
Our yearly Caregiver Conference is an opportunity for The Penn FTD Center to showcase our latest work in research and treatment for Frontotemporal Dementia (FTD) and related conditions such as ALS and Corticobasal Degeneration.
Penn Frontotemporal Degeneration Center Researchers
The research expertise at the Penn FTD Center spans many levels of neuroscience ranging from detailed clinico-pathological studies, biomarker discovery, genetics, neuropsychological studies, functional and structural neuroimaging, and cognitive neuroscience investigations of language, memory, and social cognition.
Recent Center publications have spanned such topics as white matter imaging in tauopathy forms of FTD, ALS genetic markers, and criteria for the diagnosis of primary progressive aphasia and behavioral variant FTD.
The Penn FTD Center provides an excellent training environment for undergraduate students, graduate students, clinical fellows, and research fellows to facilitate the education of the next generation of world-leading Frontotemporal degeneration experts.